HIV 1 News and Research

RSS

Study shows link between inflammatory biomarkers and prevalence of CAD in HIV-infected men

A cardiac imaging study led by Hossein Bahrami, MD, PhD, assistant professor of cardiovascular medicine at the Keck School of Medicine of the University of Southern California, along with investigators from Johns Hopkins University and five other institutions, showed a correlation between higher inflammatory biomarkers and an increased prevalence of coronary artery disease (CAD) in men infected with human immunodeficiency virus (HIV).

3 Aug 2016

GW researchers identify new way to regulate chronic toxoplasmosis

New research critical to treatment for chronic toxoplasmosis, one of the most common parasitic diseases worldwide, was published in the Journal of Experimental Medicine.

2 Aug 2016

Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research, has found that when antiretroviral therapy (ART) is initiated during early acute HIV infection, it can significantly reduce total HIV DNA levels in the body, which may have implications for the goal of achieving long-term HIV remission.

2 Aug 2016

New drug prevents vaginal and oral transmission of HIV in pre-clinical animal models

HIV remains a major health concern for women and children globally. Worldwide, the majority of new HIV infections occur in young women. Each year, 1.5 million women living with HIV become pregnant.

2 Aug 2016

Ortho Clinical Diagnostics to showcase seven posters of vital tests, six products at AACC meeting

Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry annual meeting.

30 Jul 2016

Researchers identify key immune differences that could help in development of effective HIV vaccine

One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can't seem to induce the same response.

30 Jul 2016

Researchers find different immunological profiles in HIV-infected individuals who produce bNAbs

People living with HIV who naturally produce broadly neutralizing antibodies (bNAbs) that may help suppress the virus have different immunological profiles than people who do not, researchers report.

30 Jul 2016

UW-Madison scientists working to screen mosquitoes for ability to carry, transmit Zika virus

It's no accident that researchers at the University of Wisconsin-Madison have taken a lead role addressing the Zika virus epidemic gripping the Americas. Many of them were already at work fighting viruses and mosquito-borne diseases in Central and South America.

29 Jul 2016

UofL’s CBDPP receives $2 million grant to continue oral health care services for Kentuckians living with HIV

Underserved Kentuckians living with HIV/ AIDS can continue to rely on comprehensive oral health care offered through the University of Louisville School of Dentistry, thanks to $2 million in federal funding.

29 Jul 2016

CD4/CD8 ratio biomarker could help identify HIV-infected individuals at risk for heart disease

The ratio of CD4 to CD8 T cells in the blood-a marker of immune system health and associated with mortality risk in the general population-is an independent predictor of coronary heart disease in HIV-infected patients, according to a new study published in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

29 Jul 2016

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection.

28 Jul 2016

Maternal HIV infection could alter gut microbiome of HIV-exposed, uninfected infants

A study led by researchers at The Saban Research Institute of Children's Hospital Los Angeles suggests that maternal HIV infection influences the microbiome of their HIV-uninfected infants.

28 Jul 2016

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus.

27 Jul 2016

First confirmed case of Alzheimer’s disease in HIV-positive patient to be presented at AAIC 2016

The first case of Alzheimer's disease diagnosed in an HIV-positive individual will be presented in a poster session at the Alzheimer's Association International Conference 2016 in Toronto July 27.

26 Jul 2016

Better understanding of HIV latency could be key to eradicating virus, say researchers

A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.

22 Jul 2016

Penn researchers construct model to examine how immune system may evolve to conquer HIV

It has remained frustratingly difficult to develop a vaccine for HIV/AIDS, in part because the virus, once in our bodies, rapidly reproduces and evolves to escape being killed by the immune system.

22 Jul 2016

New study reports strains of chimpanzee-carried SIVs can infect human cells

No one knows exactly how it happened. It may have entered through a cut or bite wound, the blood of a chimpanzee seeping into an exposed fingertip or forearm or foot.

22 Jul 2016

Texas Biomed scientists receive $23 million NIH grant to develop AIDS vaccine

To support a coordinated, innovative approach to the development of an AIDS vaccine, Texas Biomedical Research Institute scientists, together with a multi-institutional coalition of experts from the United States and Europe, have received a grant for $23 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

22 Jul 2016

Combining ART with immune-enhancing treatment may destabilize HIV reservoirs

Although antiretroviral therapy (ART) can reduce the amount of HIV in the blood to an undetectable level in most chronically infected people, it cannot eliminate reservoirs of HIV that persist in latently infected immune cells.

21 Jul 2016

Neutrons key to discovering new HIV drugs? An interview with Dr Matthew Blakeley

Neutron crystallography allows us to determine the three-dimensional structures of biological macromolecules, such as proteins, by means of the diffraction of neutrons from the regularly spaced atoms of a crystal.

21 Jul 2016

HIV 1 News and Research

Study shows link between inflammatory biomarkers and prevalence of CAD in HIV-infected men

GW researchers identify new way to regulate chronic toxoplasmosis

Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

New drug prevents vaginal and oral transmission of HIV in pre-clinical animal models

Ortho Clinical Diagnostics to showcase seven posters of vital tests, six products at AACC meeting

Researchers identify key immune differences that could help in development of effective HIV vaccine

Researchers find different immunological profiles in HIV-infected individuals who produce bNAbs

UW-Madison scientists working to screen mosquitoes for ability to carry, transmit Zika virus

UofL’s CBDPP receives $2 million grant to continue oral health care services for Kentuckians living with HIV

CD4/CD8 ratio biomarker could help identify HIV-infected individuals at risk for heart disease

Valley fever diagnosis often overlooked by primary care physicians

Maternal HIV infection could alter gut microbiome of HIV-exposed, uninfected infants

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

First confirmed case of Alzheimer’s disease in HIV-positive patient to be presented at AAIC 2016

Better understanding of HIV latency could be key to eradicating virus, say researchers

Penn researchers construct model to examine how immune system may evolve to conquer HIV

New study reports strains of chimpanzee-carried SIVs can infect human cells

Texas Biomed scientists receive $23 million NIH grant to develop AIDS vaccine

Combining ART with immune-enhancing treatment may destabilize HIV reservoirs

Neutrons key to discovering new HIV drugs? An interview with Dr Matthew Blakeley

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News